The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell Resolution

ObjectiveSystemic lupus erythematosus (SLE) is a complex autoimmune disease, and various immune cells are involved in the initiation, progression, and regulation of SLE. Our goal was to reveal the chromatin accessibility landscape of peripheral blood mononuclear cells (PBMCs) in SLE patients at sing...

Full description

Bibliographic Details
Main Authors: Haiyan Yu, Xiaoping Hong, Hongwei Wu, Fengping Zheng, Zhipeng Zeng, Weier Dai, Lianghong Yin, Dongzhou Liu, Donge Tang, Yong Dai
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.641886/full
_version_ 1818440533519892480
author Haiyan Yu
Haiyan Yu
Xiaoping Hong
Hongwei Wu
Fengping Zheng
Zhipeng Zeng
Weier Dai
Lianghong Yin
Dongzhou Liu
Donge Tang
Yong Dai
author_facet Haiyan Yu
Haiyan Yu
Xiaoping Hong
Hongwei Wu
Fengping Zheng
Zhipeng Zeng
Weier Dai
Lianghong Yin
Dongzhou Liu
Donge Tang
Yong Dai
author_sort Haiyan Yu
collection DOAJ
description ObjectiveSystemic lupus erythematosus (SLE) is a complex autoimmune disease, and various immune cells are involved in the initiation, progression, and regulation of SLE. Our goal was to reveal the chromatin accessibility landscape of peripheral blood mononuclear cells (PBMCs) in SLE patients at single-cell resolution and identify the transcription factors (TFs) that may drive abnormal immune responses.MethodsThe assay for transposase accessible chromatin in single-cell sequencing (scATAC-seq) method was applied to map the landscape of active regulatory DNA in immune cells from SLE patients at single-cell resolution, followed by clustering, peak annotation and motif analysis of PBMCs in SLE.ResultsPeripheral blood mononuclear cells were robustly clustered based on their types without using antibodies. We identified twenty patterns of TF activation that drive abnormal immune responses in SLE patients. Then, we observed ten genes that were highly associated with SLE pathogenesis by altering T cell activity. Finally, we found 12 key TFs regulating the above six genes (CD83, ELF4, ITPKB, RAB27A, RUNX3, and ZMIZ1) that may be related to SLE disease pathogenesis and were significantly enriched in SLE patients (p <0.05, FC >2). With qPCR experiments on CD83, ELF4, RUNX3, and ZMIZ1 in B cells, we observed a significant difference in the expression of genes (ELF4, RUNX3, and ZMIZ1), which were regulated by seven TFs (EWSR1-FLI1, MAF, MAFA, NFIB, NR2C2 (var. 2), TBX4, and TBX5). Meanwhile, the seven TFs showed highly accessible binding sites in SLE patients.ConclusionsThese results confirm the importance of using single-cell sequencing to uncover the real features of immune cells in SLE patients, reveal key TFs in SLE-PBMCs, and provide foundational insights relevant for epigenetic therapy.
first_indexed 2024-12-14T18:13:52Z
format Article
id doaj.art-db44c9e4ab9d4763b135f3206ab722b1
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-14T18:13:52Z
publishDate 2021-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-db44c9e4ab9d4763b135f3206ab722b12022-12-21T22:52:13ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-05-011210.3389/fimmu.2021.641886641886The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell ResolutionHaiyan Yu0Haiyan Yu1Xiaoping Hong2Hongwei Wu3Fengping Zheng4Zhipeng Zeng5Weier Dai6Lianghong Yin7Dongzhou Liu8Donge Tang9Yong Dai10Department of Clinical Medical Research Center, The Second Clinical Medical College, Jinan University (Shenzhen People’s Hospital), Shenzhen, ChinaThe First Affiliated Hospital, Jinan University, Guangzhou, ChinaDepartment of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, ChinaDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, ChinaDepartment of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, ChinaDepartment of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, ChinaCollege of Natural Science, University of Texas at Austin, Austin, TX, United StatesDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, ChinaDepartment of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, ChinaDepartment of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, ChinaDepartment of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, ChinaObjectiveSystemic lupus erythematosus (SLE) is a complex autoimmune disease, and various immune cells are involved in the initiation, progression, and regulation of SLE. Our goal was to reveal the chromatin accessibility landscape of peripheral blood mononuclear cells (PBMCs) in SLE patients at single-cell resolution and identify the transcription factors (TFs) that may drive abnormal immune responses.MethodsThe assay for transposase accessible chromatin in single-cell sequencing (scATAC-seq) method was applied to map the landscape of active regulatory DNA in immune cells from SLE patients at single-cell resolution, followed by clustering, peak annotation and motif analysis of PBMCs in SLE.ResultsPeripheral blood mononuclear cells were robustly clustered based on their types without using antibodies. We identified twenty patterns of TF activation that drive abnormal immune responses in SLE patients. Then, we observed ten genes that were highly associated with SLE pathogenesis by altering T cell activity. Finally, we found 12 key TFs regulating the above six genes (CD83, ELF4, ITPKB, RAB27A, RUNX3, and ZMIZ1) that may be related to SLE disease pathogenesis and were significantly enriched in SLE patients (p <0.05, FC >2). With qPCR experiments on CD83, ELF4, RUNX3, and ZMIZ1 in B cells, we observed a significant difference in the expression of genes (ELF4, RUNX3, and ZMIZ1), which were regulated by seven TFs (EWSR1-FLI1, MAF, MAFA, NFIB, NR2C2 (var. 2), TBX4, and TBX5). Meanwhile, the seven TFs showed highly accessible binding sites in SLE patients.ConclusionsThese results confirm the importance of using single-cell sequencing to uncover the real features of immune cells in SLE patients, reveal key TFs in SLE-PBMCs, and provide foundational insights relevant for epigenetic therapy.https://www.frontiersin.org/articles/10.3389/fimmu.2021.641886/fullsystemic lupus erythematosussingle-cell chromatin accessible assayperipheral blood mononuclear cellstranscription factormarker
spellingShingle Haiyan Yu
Haiyan Yu
Xiaoping Hong
Hongwei Wu
Fengping Zheng
Zhipeng Zeng
Weier Dai
Lianghong Yin
Dongzhou Liu
Donge Tang
Yong Dai
The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell Resolution
Frontiers in Immunology
systemic lupus erythematosus
single-cell chromatin accessible assay
peripheral blood mononuclear cells
transcription factor
marker
title The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell Resolution
title_full The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell Resolution
title_fullStr The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell Resolution
title_full_unstemmed The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell Resolution
title_short The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell Resolution
title_sort chromatin accessibility landscape of peripheral blood mononuclear cells in patients with systemic lupus erythematosus at single cell resolution
topic systemic lupus erythematosus
single-cell chromatin accessible assay
peripheral blood mononuclear cells
transcription factor
marker
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.641886/full
work_keys_str_mv AT haiyanyu thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT haiyanyu thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT xiaopinghong thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT hongweiwu thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT fengpingzheng thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT zhipengzeng thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT weierdai thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT lianghongyin thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT dongzhouliu thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT dongetang thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT yongdai thechromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT haiyanyu chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT haiyanyu chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT xiaopinghong chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT hongweiwu chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT fengpingzheng chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT zhipengzeng chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT weierdai chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT lianghongyin chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT dongzhouliu chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT dongetang chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution
AT yongdai chromatinaccessibilitylandscapeofperipheralbloodmononuclearcellsinpatientswithsystemiclupuserythematosusatsinglecellresolution